OCTREOTIDE SUN octreotide (as acetate) 100 microgram/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

octreotide sun octreotide (as acetate) 100 microgram/1 ml solution for injection ampoule

sun pharma anz pty ltd - octreotide -

OCTREOTIDE SUN octreotide (as acetate) 500 microgram/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

octreotide sun octreotide (as acetate) 500 microgram/1 ml solution for injection ampoule

sun pharma anz pty ltd - octreotide -

Octreotide 100 micrograms/1 ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

octreotide 100 micrograms/1 ml solution for injection

pfizer healthcare ireland - octreotide acetate - solution for injection - 100 microgram(s)/millilitre - somatostatin and analogues; octreotide

Octreotide 200 micrograms/ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

octreotide 200 micrograms/ml solution for injection

pfizer healthcare ireland - octreotide acetate - solution for injection - 200 microgram(s)/millilitre - somatostatin and analogues; octreotide

Octreotide 50 micrograms/1 ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

octreotide 50 micrograms/1 ml solution for injection

pfizer healthcare ireland - octreotide acetate - solution for injection - 50 microgram(s)/millilitre - somatostatin and analogues; octreotide

Octreotide 500 micrograms/1 ml solution for injection Ireland - English - HPRA (Health Products Regulatory Authority)

octreotide 500 micrograms/1 ml solution for injection

pfizer healthcare ireland - octreotide acetate - solution for injection - 500 microgram(s)/millilitre - somatostatin and analogues; octreotide

Octreotide Depot New Zealand - English - Medsafe (Medicines Safety Authority)

octreotide depot

teva pharma (new zealand) limited - octreotide acetate 11.2mg equivalent to octreotide 10 mg;   - powder for injection with diluent - 10 mg - active: octreotide acetate 11.2mg equivalent to octreotide 10 mg   excipient: mannitol polyglactin carmellose sodium mannitol poloxamer 188 water for injection - treatment of patients with acromegaly; in whom surgery or radiotherapy is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective. treatment of patients with symptoms associated with functional gastro-enteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas/zollinger-ellison syndrome - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas treatment of patients with progression of well-differentiated, advanced neuroendocrine tumours of the midgut or suspected midgut origin.

Octreotide Depot New Zealand - English - Medsafe (Medicines Safety Authority)

octreotide depot

teva pharma (new zealand) limited - octreotide acetate 22.4mg equivalent to octreotide 20 mg;   - powder for injection with diluent - 20 mg - active: octreotide acetate 22.4mg equivalent to octreotide 20 mg   excipient: mannitol polyglactin carmellose sodium mannitol poloxamer 188 water for injection - treatment of patients with acromegaly; in whom surgery or radiotherapy is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective. treatment of patients with symptoms associated with functional gastro-enteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas/zollinger-ellison syndrome - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas treatment of patients with progression of well-differentiated, advanced neuroendocrine tumours of the midgut or suspected midgut origin.

Octreotide Depot New Zealand - English - Medsafe (Medicines Safety Authority)

octreotide depot

teva pharma (new zealand) limited - octreotide acetate 33.6mg equivalent to octreotide 30 mg;   - powder for injection with diluent - 30 mg - active: octreotide acetate 33.6mg equivalent to octreotide 30 mg   excipient: mannitol polyglactin carmellose sodium mannitol poloxamer 188 water for injection - treatment of patients with acromegaly; in whom surgery or radiotherapy is inappropriate or ineffective, or in the interim period until radiotherapy becomes fully effective. treatment of patients with symptoms associated with functional gastro-enteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas/zollinger-ellison syndrome - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas treatment of patients with progression of well-differentiated, advanced neuroendocrine tumours of the midgut or suspected midgut origin.

SANDOSTATIN LAR 30 MG Israel - English - Ministry of Health

sandostatin lar 30 mg

novartis israel ltd - octreotide - powder and solvent for suspension for injection - octreotide 30 mg - octreotide - octreotide - treatment of acromegaly in: patients already adequately controlled on standard doses of sandostatin s.c. patients in whom surgery or radiotherapy are inappropriate or ineffective, or who are in the latency period before radiotherapy becomes fully effective.endocrine gastro-entero- pancreatic (gep) tumors, carcinoid tumors.